BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol 2021. [PMID: 34292611 DOI: 10.1111/cup.14104] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Pira A, Sinagra JLM, Moro F, Mariotti F, Di Zenzo G. Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine. Front Med 2023;10. [DOI: 10.3389/fmed.2023.1112823] [Reference Citation Analysis]
2 Ferreira-da-silva R, Ribeiro-vaz I, Silva AM, Nunes F, Morato M, Polónia JJ, Guedes P. Delayed Extensive Local Reaction to the mRNA-1273 Vaccine against SARS-CoV-2: A Case Report. Journal of Pharmacology and Pharmacotherapeutics 2023. [DOI: 10.1177/0976500x221147748] [Reference Citation Analysis]
3 Agustin M, Trifitriana M, Danarti R. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review. BMC Infect Dis 2023;23:7. [PMID: 36609222 DOI: 10.1186/s12879-022-07973-4] [Reference Citation Analysis]
4 Bunch CM, Zackariya N, Thomas AV, Langford JH, Aboukhaled M, Thomas SJ, Ansari A, Patel SS, Buckner H, Miller JB, Annis CL, Quate-Operacz MA, Schmitz LA, Pulvirenti JJ, Konopinski JC, Kelley KM, Hassna S, Nelligan LG, Walsh MM. COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report. Clin Case Rep 2022;10:e6790. [PMID: 36590660 DOI: 10.1002/ccr3.6790] [Reference Citation Analysis]
5 Corrà A, Verdelli A, Mariotti EB, Ruffo di Calabria V, Quintarelli L, Aimo C, Sunderkötter CH, Caproni M. Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination. Front Med (Lausanne) 2022;9:1013846. [PMID: 36569148 DOI: 10.3389/fmed.2022.1013846] [Reference Citation Analysis]
6 Chomičienė A, Černiauskas K, Linauskienė K, Meškauskas R, Malinauskienė L. Two case reports of skin vasculitis following the COVID-19 immunization. Open Med (Wars) 2022;17:1944-8. [PMID: 36561846 DOI: 10.1515/med-2022-0608] [Reference Citation Analysis]
7 Gay J, Trivedi N, Simpson S, Grider D. Persistent Rash After COVID-19 Vaccination: Answer. The American Journal of Dermatopathology 2022;44:1005-1006. [DOI: 10.1097/dad.0000000000002299] [Reference Citation Analysis]
8 Yan M, Zhao H, Li Z, Chow J, Zhang Q, Qi Y, Wu S, Zhong M, Qiu X. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.921760] [Reference Citation Analysis]
9 Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. CCID 2022;Volume 15:2369-2382. [DOI: 10.2147/ccid.s388245] [Reference Citation Analysis]
10 Matsuoka A, Higashi Y, Kanekura T. Erythema nodosum at COVID-19 vaccine injection site. J Dermatol 2023;50:e83-4. [PMID: 36282881 DOI: 10.1111/1346-8138.16613] [Reference Citation Analysis]
11 Wan V, Chen D, Shiau CJ, Jung GW. Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review. SAGE Open Med Case Rep 2022;10:2050313X221131868. [PMID: 36274858 DOI: 10.1177/2050313X221131868] [Reference Citation Analysis]
12 Girolami I, Eisendle K, Kluge RW, Hanspeter E, Eccher A, Vizziello L, Zampieri P, Mazzoleni G. Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine. Pathologica 2022;114:322-325. [DOI: 10.32074/1591-951x-746] [Reference Citation Analysis]
13 Rodríguez Y, Rojas M, Beltrán S, Polo F, Camacho-Domínguez L, Morales SD, Gershwin ME, Anaya JM. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun 2022;132:102898. [PMID: 36041291 DOI: 10.1016/j.jaut.2022.102898] [Reference Citation Analysis]
14 Maronese CA, Zelin E, Avallone G, Moltrasio C, Romagnuolo M, Ribero S, Quaglino P, Marzano AV. Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med 2022;9. [DOI: 10.3389/fmed.2022.996288] [Reference Citation Analysis]
15 Garcia-blanco L, Celorio-murillo W, Delgado V. Vasculitis leucocitoclástica asociada a la vacuna ARNm contra la COVID-19. Piel 2022;37:S18-S20. [DOI: 10.1016/j.piel.2022.04.001] [Reference Citation Analysis]
16 Conticini E, d'Alessandro M, Grazzini S, Fornaro M, Sabella D, Lopalco G, Giardina F, Colafrancesco S, Rizzo C, Guggino G, Priori R, Conti F, Iannone F, Bargagli E, Cantarini L, Frediani B. Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study. Intern Emerg Med 2022. [PMID: 35754076 DOI: 10.1007/s11739-022-03028-3] [Reference Citation Analysis]
17 de Lorenzi C, Kaya G, Toutous Trellu L. Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine. Dermatopathology (Basel) 2022;9:203-6. [PMID: 35892478 DOI: 10.3390/dermatopathology9030025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Ryoo Y, Kim Y, Yun J, Kim S. A Case of Leukocytoclastic Vasculitis Following COVID-19 Vaccination. Keimyung Med J 2022;41:46-49. [DOI: 10.46308/kmj.2022.00010] [Reference Citation Analysis]
19 Lian BS, Choo KJL, Chong CJ, Hanif IM, Naing CS, Lee HY. Injection site reactions after COVID-19 mRNA vaccination. Ann Acad Med Singap 2022;51:247-249. [DOI: 10.47102/annals-acadmedsg.2021508] [Reference Citation Analysis]
20 Kurosaki Y, Ishitsuka Y, Kato Y, Arase N, Fujiomto M. Blistering Papulosquamous Erythema with Arthralgia: A Quiz. Acta Derm Venereol 2022;102:adv00690. [DOI: 10.2340/actadv.v102.936] [Reference Citation Analysis]
21 Pauluzzi M, Stinco G, Errichetti E. Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review. J Eur Acad Dermatol Venereol 2022;36:e257-9. [PMID: 34928518 DOI: 10.1111/jdv.17891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review. Microorganisms 2022;10:624. [DOI: 10.3390/microorganisms10030624] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Calabria E, Canfora F, Mascolo M, Varricchio S, Mignogna MD, Adamo D. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: a case report of pemphigus vulgaris and a literature review. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153834] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
24 Maronese CA, Caproni M, Moltrasio C, Genovese G, Vezzoli P, Sena P, Previtali G, Cozzani E, Gasparini G, Parodi A, Atzori L, Antiga E, Maglie R, Moro F, Mariotti EB, Corrà A, Pallotta S, Didona B, Marzano AV, Di Zenzo G. Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study. Front Med (Lausanne) 2022;9:841506. [PMID: 35295599 DOI: 10.3389/fmed.2022.841506] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
25 Alamri A, Alghamdi Y, Alamri SJ, Althaqafi MK, Alqurashi W, Bader BA, Mohanna AT, Almahdi B. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. Cureus 2022. [DOI: 10.7759/cureus.22414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Avallone G, Quaglino P, Cavallo F, Roccuzzo G, Ribero S, Zalaudek I, Conforti C. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol 2022. [PMID: 35141881 DOI: 10.1111/ijd.16063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
27 Gambichler T, Abu Rached N, Scholl L, Behle B, Mansour R, Nick M, Susok L. Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination. J Dermatol 2022. [PMID: 35141951 DOI: 10.1111/1346-8138.16282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu K, Chao Y. New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine. Dermatol Sin 2022;40:245. [DOI: 10.4103/1027-8117.358000] [Reference Citation Analysis]
29 Đorđević Betetto L, Luzar B, Pipan Tkalec Ž, Ponorac S. Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review. Acta Dermatovenerologica Alpina Pannonica et Adriatica 2022;31. [DOI: 10.15570/actaapa.2022.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kim DH, Cho JH, Park SJ, Seo SH, Ahn HH. Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea. J Korean Med Sci 2022;37:e190. [DOI: 10.3346/jkms.2022.37.e190] [Reference Citation Analysis]
31 Fiorillo G, Pancetti S, Cortese A, Toso F, Manara S, Costanzo A, Borroni RG. Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination. J Autoimmun 2021;127:102783. [PMID: 34973526 DOI: 10.1016/j.jaut.2021.102783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
32 Yatsuzuka K, Murakami M, Kuroo Y, Fukui M, Yoshida S, Muto J, Shiraishi K, Sayama K. Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination. J Dermatol 2021. [PMID: 34862669 DOI: 10.1111/1346-8138.16271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Pourani MR, Shahidi Dadras M, Salari M, Diab R, Namazi N, Abdollahimajd F. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients. Dermatol Ther 2021;:e15223. [PMID: 34820975 DOI: 10.1111/dth.15223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
34 Martora F, Fabbrocini G, Marasca C. Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series. Dermatol Ther 2021;:e15225. [PMID: 34816549 DOI: 10.1111/dth.15225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Henry D, Henry D. Herpes zoster following ChAdOx1 nCoV-19 corona virus vaccine (recombinant): A case report. JSSTD 2021;4:136-138. [DOI: 10.25259/jsstd_73_2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Dell'Antonia M, Anedda S, Usai F, Atzori L, Ferreli C. Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy. Dermatol Ther 2021;:e15208. [PMID: 34786801 DOI: 10.1111/dth.15208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
37 Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. J Clin Med 2021;10:5344. [PMID: 34830627 DOI: 10.3390/jcm10225344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
38 Grossman ME, Appel G, Little AJ, Ko CJ. Post-COVID-19 vaccination IgA vasculitis in an adult. J Cutan Pathol 2021. [PMID: 34779011 DOI: 10.1111/cup.14168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
39 Cowan T, Wallman L, Murrell D. Vaxzevria COVID-19 aşısı sonrasında gelişen şiddetli büllöz pemfigoid. Mucosa 2021. [DOI: 10.33204/mucosa.993581] [Reference Citation Analysis]
40 Baffa ME, Maglie R, Giovannozzi N, Montefusco F, Senatore S, Massi D, Antiga E. Sweet Syndrome Following SARS-CoV2 Vaccination. Vaccines (Basel) 2021;9:1212. [PMID: 34835143 DOI: 10.3390/vaccines9111212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
41 Grieco T, Maddalena P, Sernicola A, Muharremi R, Basili S, Alvaro D, Cangemi R, Rossi A, Pellacani G. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study. Dermatol Ther 2021;34:e15153. [PMID: 34622531 DOI: 10.1111/dth.15153] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
42 Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology (Basel) 2021;8:463-76. [PMID: 34698094 DOI: 10.3390/dermatopathology8040049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]